financetom
Business
financetom
/
Business
/
US FTC's bid to block Tapestry-Capri merger goes to trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FTC's bid to block Tapestry-Capri merger goes to trial
Sep 9, 2024 4:11 AM

NEW YORK (Reuters) - The U.S. Federal Trade Commission will urge a federal judge in New York to block Tapestry's $8.5 billion merger with rival handbag maker Capri Holdings ( CPRI ) at a trial beginning on Monday, arguing it will eliminate fierce competition in the market for "accessible luxury."

The FTC argues the merger announced in August 2023 would eliminate head-to-head competition between Tapestry's Coach and Kate Spade brands and Capri's Michael Kors' brands, which has resulted in better prices, discounts and promotions for consumers and wages and workplace benefits for employees.

The deal would also give Tapestry a dominant share of the "accessible luxury" handbag market, a term coined by Tapestry to describe quality leather and craftsmanship handbags at an affordable price, the FTC said in its April lawsuit.

Tapestry, in response, argues that the FTC's analysis misunderstands the handbag marketplace and the way consumers shop, and that "accessible luxury" is a notional concept. The U.S. handbag market, they say, is highly fragmented and competitive with low barriers to entry and fickle consumer tastes.

The FTC has sued to block several mergers over the past year, making for a busy schedule.

The antitrust regulator is currently fighting to block supermarket chain Kroger's ( KR ) acquisition of Albertsons ( ACI ) in a federal court in Portland, Oregon and has also sued to block the $4 billion acquisition of Mattress Firm by mattress manufacturer Tempur Sealy International ( TPX ).

Monday's trial, overseen by District Court Judge Jennifer Rochon for the Southern District of New York, is expected to last for a week and a half.

The brands are likely to call Jeff Gennette, the former CEO of Macy's, to testify about the range of handbag choices available to shoppers, while the FTC is expected to offer evidence about the physical similarities between each company's bags and how Americans respond to changes in handbag prices.

The trial follows the merger's approval by antitrust regulators in Japan and the European Union earlier this year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved